Malignant peritoneal mesothelioma

Journal of Surgical Oncology

Volumn 91, Issue 1, 2005, Pages 17-25

  Bani Hani, Kamal E ^a,b   Gharaibeh, Kamal A ^a  

^a KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Asbestos; Familial mediterranean fever; Malignant peritoneal mesothelioma; Mesothelioma; Peritoneal malignancy

Indexed keywords

ANTINEOPLASTIC AGENT; ASBESTOS;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ERROR; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HISTOLOGY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; MALE; PERITONEUM MESOTHELIOMA; PEROPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASBESTOS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CISPLATIN; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DOXORUBICIN; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, PARENTERAL; MALE; MESOTHELIOMA; MESOTHELIOMA, CYSTIC; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 22044442528     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20266     Document Type: Review

References (56)

1. Ivaldi C, Dalmasso P, Nesti M, et al.: Malignant mesothelioma registry from Piedmont. Incidence in 1990-1995. Epidemiol Prev 1999;23:308-315.
2. Price B: Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 1997;145:211-218.
3. Miller J, Wynn H: A malignant tumour arising from the endothelium of the peritoneum and producing a mucoid ascitic fluid. J Pathol Bacteriol 1908;12:267.
4. Sebbag G, Yan H, Shmookler BM, et al.: Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 2000;87: 1587-1593.
5. Piazza D, Caruso F, Scaringi S, et al.: Primary diffuse malignant peritoneal mesothelioma: Case report and update of therapy. J Surg Oncol 2000;75:55-58.
6. Clark JR, Ross WB: An unusual case of ascites: Pitfalls in diagnosis of malignant peritoneal mesothelioma. Aust N Z J Surg 2000;70:384-388.
7. Shivapurkar N, Wiethege T, Wistuba II, et al.: Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999;76:181-188.
8. Sato F, Yamazaki H, Ataka K, et al.: Malignant peritoneal mesothelioma associated with deep vein thrombosis following radiotherapy for seminoma of the testis. Intern Med 2000;39:920-924.
9. Weissmann LB, Corson JM, Neugut AI, et al.: Malignant mesothelioma following treatment for Hodgkin's disease. J Clin Oncol 1996;14:2098-2100.
10. Stey C, Landolt-Weber U, Vetter W, et al.: Malignant peritoneal mesothelioma after Thorotrast exposure. Am J Clin Oncol 1995; 18:313-317.
11. Attanoos RL, Gibbs AR: Pathology of malignant mesothelioma. Histopathology 1997;30:403-418.
12. Gentiloni N, Febbraro S, Barone C, et al.: Peritoneal mesothelioma in recurrent familial peritonitis. J Clin Gastroenterol 1997;24:276-279.
13. Dourthe LM, Coulon MA, Piperno Neumann S, et al.: Peritoneal mesothelioma, a new complication of pica syndrome: Apropos of a case. Rev Med Interne 1999;20:1047-1048.
14. Wagner JC, Sleegs CA, Marchand P: Diffuse pleural mesothelioma. Br J Ind Med 1960;17:260-271.
15. D'Albuquerque LA, Padilla JM, Rodrigues AL, et al.: Diffuse primary malignant mesothelioma in abdominal cavity. Arq Gastroenterol 1997;34:163-168.
16. Barbieri PG, Migliori M, Merler E: The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, Northern Italy. Med Lav 1999;90:762-775.
17. Cocco P, Dosemeci M: Peritoneal cancer and occupational exposure to asbestos: Results from the application of a job-exposure matrix. Am J Ind Med 1999;35:9-14.
18. Stamat JC, Chekan EG, Ali A, et al.: Laparoscopy and mesothelioma. J Laparoendosc Adv Surg Tech A 1999;9:433-437.
19. Jarvholm B, Sanden A: Lung cancer and mesothelioma in the pleura and peritoneum among Swedish insulation workers. Occup Environ Med 1998;55:766-770.
20. Dodson RF, O'Sullivan MF, Huang J, et al.: Asbestos in extrapulmonary sites: Omentum and mesentery. Chest 2000;117:486-493.
21. Neumann V, Muller KM, Fischer M: Peritoneal mesothelioma - incidence and etiology. Pathologe 1999;20:169-176.
22. Bisconti M, Bisetti A, Bidoli P: Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: Only an apparent association? Respiration 2000;67:223-228.
23. Mohamed F, Sugarbaker PH: Peritoneal mesothelioma. Curr Treat Options Oncol 2002;3:375-386.
24. Acherman YI, Welch LS, Bromley CM, et al.: Clinical presentation of peritoneal mesothelioma. Tumori 2003;89:269-273.
25. Ustundag Y, Can U, Benli S, et al.: Internal carotid artery occlusion in a patient with malignant peritoneal mesothelioma: Is it a sign of malignancy-related thrombosis? Am J Med Sci 2000; 319:265-267.
26. Tejido Garcia R, Anta Fernandez M, Hernandez Hernandez JL, et al.: Fever of unknown origin as the clinical presentation of malignant peritoneal mesothelioma. An Med Interna 1997;14: 573-575.
27. Van de Walle P, Blomme Y, Van Outryve L: Laparoscopy and primary diffuse malignant peritoneal mesothelioma: A diagnostic challenge. Acta Chir Belg 2004;104:114-117.
28. Sugarbaker PH, Yan H, Grazi RV, et al.: Early localized peritoneal mesothelioma as an incidental finding at laparoscopy. Report of a case and implications regarding natural history of the disease. Cancer 2000;89:1279-1284.
29. Orosz Z, Nagy P, Szentirmay Z, et al.: Epithelial mesothelioma with deciduoid features. Virchows Arch 1999;434:263-266.
30. Muensterer OJ, Averbach AM, Jacquet P, et al.: Malignant peritoneal mesothelioma. Case-report demonstrating pitfalls of diagnostic laparoscopy. Int Surg 1997;82:240-243.
31. Ros PR, Yuschok TJ, Buck JL, et al.: Peritoneal mesothelioma. Radiologic appearances correlated with histology. Acta Radiol 1991;32:355-358.
32. Smith TR: Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging 1994;19:27-29.
33. Gupta S, Gupta RK, Gujral RB, et al.: Peritoneal mesothelioma simulating pseudomyxoma peritonei on CT and sonography. Gastrointest Radiol 1992;17:129-131.
34. Asensio JA, Goldblatt P, Thomford NR: Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 1990;125:1477-1481.
35. Ordonez NG: Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 1998;22:1203-1214.
36. Attanoos RL, Webb R, Dojcinov SD, et al.: Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002;40:237-244.
37. Almudevar Bercero E, Garcia-Rostan Perez GM, Garcia Bragado F, et al.: Prognostic value of high serum levels of CA-125 in malignant secretory peritoneal mesotheliomas affecting young women. A case report with differential diagnosis and review of the literature. Histopathology 1997;31:267-273.
38. Amodio A, Crecco M, Del Medico P, et al.: Gemcitabine in peritoneal mesothelioma: A case report. Clin Ter 1998;149:447-451.
39. Churg A, Colby TV, Cagle P, et al.: The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000;24: 1183-1200.
40. Mohamed F, Sethna K, Elias D, et al.: Challenging and unusual cases: Case 3. Peritoneal cystic mesothelioma. J Clin Oncol 2003;21:1419-1420.
41. Gonzalez-Moreno S, Yan H, Alcorn KW, et al.: Malignant transformation of "benign" cystic mesothelioma of the peritoneum. J Surg Oncol 2002;79:243-251.
42. Sethna K, Mohamed F, Marchettini P, et al.: Peritoneal cystic mesothelioma: A case series. Tumori 2003;89:31-35.
43. Weiss SW, Tavassoli FA: Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 1988;12:737-746.
44. DeStephano DB, Wesley JR, Heidelberger KP, et al.: Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: Report of a case. Pediatr Pathol 1985;4:291-302.
45. Sugarbaker PH, Welch LS, Mohamed F, et al.: A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 2003;12:605-621.
46. Sugarbaker PH: Management of peritoneal surface malignancy. Preface Surg Oncol Clin N Am 2003;12:xxi-xxiv.
47. Sugarbaker PH. Re: Verwaal VJ, van Tinteren H, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004;85:61-67.
48. J Surg Oncol 2004; 88:276-278.
49. Sugarbaker PH: Peritonectomy procedures. Surg Oncol Clin N Am 2003;12:703-727.
50. Yan TD, Haveric N, Carmignani CP, et al.: Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005;103:839-849.
51. Begossi G, Gonzalez-Moreno S, Ortega-Perez G, et al.: Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis, and mesothelioma. Eur J Surg Oncol 2002;28:80-87.
52. Sugarbaker PH, Acherman YI, Gonzalez-Moreno S, et al.: Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol 2002;29:51-61.
53. Soulie P, Ruffie P, Trandafir L, et al.: Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a. J Clin Oncol 1996;14:878-885.
54. Westermann AM, Dubbelman R, Moolenaar WH, et al.: Successful intraperitoneal suramin treatment of peritoneal mesothelioma. Ann Oncol 1997;8:801-802.
55. Hoff CM, Shockley TR: The potential of gene therapy in the peritoneal cavity. Perit Dial Int 1999;19:S202-S207.
56. Levine EA: Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers. Mod Pathol 2004;17:476-481.